Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Pediatrix Medical (MD) over the last 10 years, with Q3 2025 value amounting to $56.7 million.

  • Pediatrix Medical's Other Accumulated Expenses changed N/A to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.7 million, marking a year-over-year change of. This contributed to the annual value of $62.9 million for FY2024, which is 3591.41% up from last year.
  • Pediatrix Medical's Other Accumulated Expenses amounted to $56.7 million in Q3 2025.
  • In the past 5 years, Pediatrix Medical's Other Accumulated Expenses ranged from a high of $68.4 million in Q4 2022 and a low of $46.3 million during Q4 2023
  • Moreover, its 4-year median value for Other Accumulated Expenses was $57.7 million (2025), whereas its average is $57.7 million.
  • As far as peak fluctuations go, Pediatrix Medical's Other Accumulated Expenses plummeted by 3238.11% in 2023, and later skyrocketed by 3591.41% in 2024.
  • Over the past 4 years, Pediatrix Medical's Other Accumulated Expenses (Quarter) stood at $68.4 million in 2022, then plummeted by 32.38% to $46.3 million in 2023, then soared by 35.91% to $62.9 million in 2024, then decreased by 9.81% to $56.7 million in 2025.
  • Its Other Accumulated Expenses stands at $56.7 million for Q3 2025, versus $57.6 million for Q2 2025 and $57.8 million for Q1 2025.